Antisense Therapeutics Limited (ANP) Company Profile

Antisense Therapeutics Limited Company Snapshot

Antisense Therapeutics Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Antisense Therapeutics Limited with three other companies in this sector in Australia: Actinogen Medical Ltd (2017 sales of 155,768.00 Australian Dollars [US$119,545.71 ] ), Zelda Therapeutics Ltd (167,757.00 Australian Dollars [US$128,746.79 ] ), and CropLogic Ltd (125,452.88 Australian Dollars [US$96,280.07 ] ).

Sales Analysis. Sales fell dramatically in 2017: Antisense Therapeutics Limited reported sales of A$140,169.00 (US$107.57 thousand) for the fiscal year ending June of 2017. This represents a sharp decrease of 87.6% versus 2016, when the company's sales were A$1.13 million.

Antisense Therapeutics Limited

Stock Data:

Recent Stock Performance:

Current Price (4/20/2018): .03
(Figures in Australian Dollars)

1 Week	-10.3%	13 Weeks	-29.5%

4 Weeks	-17.5%	52 Weeks	-12.5%

Antisense Therapeutics Limited Key Data:

Ticker:	ANP	Country:	Australia

Exchanges:		Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2017 Sales	140,169 (Year Ending Jan 2018).	Employees:	8

Currency:	Australian Dollars	Market Cap:	4,667,272

Fiscal Yr Ends:	June	Shares Outstanding:	179,510,453

Share Type:	Ordinary	Closely Held Shares:	57,279,624

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.